Science & innovation

Baxter’s diverse scientific expertise and world-class capabilities in key technical areas are critical components in advancing patient care globally.

Baxter Ventures: Investing in Innovation

Baxter Ventures was created in 2011 by Baxter International Inc., which has an 85-year legacy of supporting healthcare innovation and saving and sustaining lives worldwide. Baxter Ventures invests in companies with innovative technologies, products, and therapies that have the ability to accelerate growth for the company as well as make meaningful advancements in patient care. Its focus includes therapeutic areas complementary to those of Baxter’s Hospital Products and Renal business segments, as well as cutting-edge technologies and therapies outside of its current product portfolio that have the potential for sustainable long-term growth and to address unmet clinical need.

Investment Focus

Our focus includes therapeutic areas complementary to those of our hospital products and renal businesses, as well as cutting-edge technologies and therapies with sustainable long-term growth potential positioned to change the paradigm of acute and chronic healthcare. Each investment opportunity undergoes a rigorous process to evaluate the ability to improve patient care and maximize value.

Areas of Interest Include:

  • In-Hospital Solutions and Therapeutics
  • Critical Care
  • Surgical Care
  • Medical Devices
  • Monitoring and Diagnostic Tools
  • Medication Deliver and Management
  • Pharmacy Technology Tools
  • Renal Therapies
  • Healthcare Information Technology

Contact Us

We can be reached at ventures@baxter.com. Please include the following non-confidential information and we will respond if there is sufficient interest and alignment for investment.

  • Company name, primary contact name and contact information
  • Brief, non-confidential description or overview material
a wall